Temporal trends in vena cava filter implantation in public health system inpatients: an 11-year analysis of the largest city in Brazil
Tendência temporal do implante de filtro de veia cava em pacientes internados no SUS em São Paulo: análise de 11 anos da maior cidade do Brasil
Dafne Braga Diamante Leiderman; Marcelo Fiorelli; Marcelo Passos Teivelis; Nickolas Stabellini; Edson Amaro Júnior; Nelson Wolosker
Abstract
Keywords
Resumo
Resumo:
Palavras-chave
References
1 Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006;21(7):722-7.
2 Barginear MF, Lesser M, Akerman ML, et al. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome. Clin Appl Thromb Hemost. 2009;15(3):263-9.
3 Zerati AE, Wolosker N, Yazbek G, Langer M, Nishinari K. Vena cava filters in cancer patients: experience with 50 patients. Clinics. 2005;60(5):361-6.
4 Wolosker N, Varella AYM, Fukuda JM, et al. Enoxaparin Treatment Followed by Rivaroxaban for the Treatment of Acute Lower Limb Venous Thromboembolism: Initial Experience in a Single Center. Clin Appl Thromb Hemost. 2016;22(4):377-80.
5 Pignataro BS, Nishinari K, Cavalcante RN, et al. Oral rivaroxaban for the treatment of symptomatic venous thromboembolism in 400 patients with active cancer. Clin Appl Thromb Hemost. 2017;23(7):883-7. PMid:28027659.
6 Schwarz RE, Marrero AM, Conlon KC, Burt M. Inferior vena cava filters in cancer patients: indications and outcome. J Clin Oncol. 1996;14(2):652-7.
7 Seddighzadeh A, Shetty R, Goldhaber SZ. 1,096 cancer patients with DVT: lower prophylaxis rates but more frequent inferior vena cava filter insertion. Chest. 2007;132(4):499A.
8 Wang SL, Lloyd AJ. Clinical review: inferior vena cava filters in the age of patient-centered outcomes. Ann Med. 2013;45(7):474-81.
9 Hajduk B, Tomkowski WZ, Malek G, Davidson BL. Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study. Chest. 2010;137(4):877-82.
10 The PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416-22.
11 Brasil. Centro Cultural do Ministério da Saúde – CCS [site na Internet]. 2021 [cited 2021 nov 8].
12 Agência Nacional de Saúde Suplementar – ANS [site na Internet]. 2021 [cited 2021 nov 8].
13 World Health Organization – WHO [site na Internet]. 2021 [cited 2021 nov 8].
14 DATASUS [site na Internet]. 2021 [cited 2021 nov 8].
15 Charalel RA, Durack JC, Mao J, Ross JS, Meltzer AJ, Sedrakyan A. Statewide inferior vena cava filter placement, complications, and retrievals: epidemiology and recent trends. Med Care. 2018;56(3):260-5.
16 Power JR, Nakazawa KR, Vouyouka AG, Faries PL, Egorova NN. Trends in vena cava filter insertions and “prophylactic” use. J Vasc Surg Venous Lymphat Disord. 2018;6(5):592-98.e6.
17 Belkin N, Jackson BM, Foley PJ, et al. Trends in inferior vena cava filter placement and retrieval at a tertiary care institution. J Vasc Surg Venous Lymphat Disord. 2019;7(3):405-12.
18 Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-52.
19 Abdel-Razeq H, Mansour A, Ismael Y, Abdulelah H. Inferior vena cava filters in cancer patients: to filter or not to filter. Ther Clin Risk Manag. 2011;7:99-102.
20 Ramacciotti E, Wolosker N, Puech-Leão P, et al. Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis. Thromb Res. 2003;109(4):171-4.
21 Cantelmo NL, Menzoian JO, Logerfo FW, Fasulo G, Mozden PJ. Clinical experience with vena caval filters in high-risk cancer patients. Cancer. 1982;50(2):341-4.
22 Dewdney SB, Benn T, Rimel BJ, et al. Inferior vena cava filter placement in the gynecologic oncology patient: a 15-year institutional experience. Gynecol Oncol. 2011;121(2):344-6.
23 Mansour A, Ismael Y, Abdel-Razeq H. Inferior vena cava filters in patients with advanced-stage cancer. Hematol Oncol Stem Cell Ther. 2014;7(4):136-41.
24 Matei DE, Marder VJ. Hereditary and acquired thrombophilic syndromes. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and thrombosis: basic principles and clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. 16 p.
25 Krutman M, Wolosker N, Kuzniec S, de Campos Guerra JC, Tachibana A, Almeida Mendes C. Risk of asymptomatic pulmonary embolism in patients with deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2013;1(4):370-5.
26 Kakkar AK. Cancer-associated thrombosis. Br J Cancer. 2010;102(Suppl. 1):S1-1.
27 Leiderman DBD, Zerati AE, Vieira Mariz MP, Wolosker N, Puech-Leão P, Luccia N. The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis. Ann Vasc Surg. 2019;60:35-44.
28 Braga Mendes G, Zanetti G, Marchiori E. Vena cava filter complications. Arch Bronconeumol. 2019;55(3):173-4. PMid:30190226.
29 Alkhouli M, Morad M, Narins CR, Raza F, Bashir R. Inferior vena cava thrombosis. JACC Cardiovasc Interv. 2016;9(7):629-43.
31 Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med. 2011;124(7):655-61.
32 Spencer FA, Bates SM, Goldberg RJ, et al. A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med. 2010;170(16):1456-62.
33 Zoltowska DM, Thind GS, Agrawal Y, Kalavakunta JK, Joseph S, Patri S. Trends in vena cava filter placement: an analysis of nationwide inpatient sample database over an 11 year period. Rev Recent Clin Trials. 2018;13(4):305-11.
34 Ahmed O, Patel K, Patel MV, et al. Declining national annual IVC filter utilization: an analysis on the impact of societal and governmental communications. Chest. 2017;151(6):1402-4.
35 Idakoji I, Kuo W, Deso S. Evidence-based evaluation of inferior vena cava filter complications based on filter type. Semin Intervent Radiol. 2016;33(2):93-100.
36 Muriel A, Jiménez D, Aujesky D, et al. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol. 2014;63(16):1675-83.
37 Wadhwa V, Trivedi PS, Chatterjee K, et al. Decreasing Utilization of Inferior Vena Cava Filters in Post-FDA Warning Era: Insights From 2005 to 2014 Nationwide Inpatient Sample. J Am Coll Radiol. 2017;14(9):1144-50.
38 Phair J, Denesopolis J, Lipsitz EC, Scher L. Inferior vena cava filter malpractice litigation: damned if you do, damned if you don’t. Ann Vasc Surg. 2018;50:15-20.
39 Stabellini N, Wolosker N, Leiderman DBD, et al. Epidemiological analysis of carotid artery stenosis intervention during 10 years in the public health system in the largest city in Brazil: stenting has been more common than endarterectomy. Ann Vasc Surg. 2020;66:378.
Submitted date:
11/08/2021
Accepted date:
01/26/2022
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email